Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127904) titled 'A multicenter, prospective, randomized controlled clinical trial comparing the efficacy of LDA, LHAA, and LA regimens in young adults with intermediate-to-high risk acute myeloid leukemia eligible for intensive chemotherapy' on July 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Condition:
Newly diagnosed intermediate-to-high risk acute myeloid leukemia
Intervention:
Arm C:Lisaftoclax + Azacitidine
Arm B:Lisaftoclax+homoharringtonine+cytarabine+aclarubicin
Recruitment Status: Not Recruiting
Phase: N/A
...